PRPF6
Pre-mRNA-processing factor 6
Also known as: ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, PRP6_HUMAN, RP60, SNRNP102, TOM, U5-102K
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O94906
- Gene
- PRPF6
- Ensembl
- ENSG00000101161
- Chromosome
- 20
- Canonical length
- 941 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles,Vesicles,Centrosome,Basal body,Cytosol
OverviewNCBI Gene
The protein encoded by this gene appears to be involved in pre-mRNA splicing, possibly acting as a bridging factor between U5 and U4/U6 snRNPs in formation of the spliceosome. The encoded protein also can bind androgen receptor, providing a link between transcriptional activation and splicing. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
941 residues, UniProt reviewed canonical sequence.
>O94906|PRPF6
1 MNKKKKPFLG MPAPLGYVPG LGRGATGFTT RSDIGPARDA NDPVDDRHAP PGKRTVGDQM
61 KKNQAADDDD EDLNDTNYDE FNGYAGSLFS SGPYEKDDEE ADAIYAALDK RMDERRKERR
121 EQREKEEIEK YRMERPKIQQ QFSDLKRKLA EVTEEEWLSI PEVGDARNKR QRNPRYEKLT
181 PVPDSFFAKH LQTGENHTSV DPRQTQFGGL NTPYPGGLNT PYPGGMTPGL MTPGTGELDM
241 RKIGQARNTL MDMRLSQVSD SVSGQTVVDP KGYLTDLNSM IPTHGGDIND IKKARLLLKS
301 VRETNPHHPP AWIASARLEE VTGKLQVARN LIMKGTEMCP KSEDVWLEAA RLQPGDTAKA
361 VVAQAVRHLP QSVRIYIRAA ELETDIRAKK RVLRKALEHV PNSVRLWKAA VELEEPEDAR
421 IMLSRAVECC PTSVELWLAL ARLETYENAR KVLNKARENI PTDRHIWITA AKLEEANGNT
481 QMVEKIIDRA ITSLRANGVE INREQWIQDA EECDRAGSVA TCQAVMRAVI GIGIEEEDRK
541 HTWMEDADSC VAHNALECAR AIYAYALQVF PSKKSVWLRA AYFEKNHGTR ESLEALLQRA
601 VAHCPKAEVL WLMGAKSKWL AGDVPAARSI LALAFQANPN SEEIWLAAVK LESENDEYER
661 ARRLLAKARS SAPTARVFMK SVKLEWVQDN IRAAQDLCEE ALRHYEDFPK LWMMKGQIEE
721 QKEMMEKARE AYNQGLKKCP HSTPLWLLLS RLEEKIGQLT RARAILEKSR LKNPKNPGLW
781 LESVRLEYRA GLKNIANTLM AKALQECPNS GILWSEAIFL EARPQRRTKS VDALKKCEHD
841 PHVLLAVAKL FWSQRKITKA REWFHRTVKI DSDLGDAWAF FYKFELQHGT EEQQEEVRKR
901 CESAEPRHGE LWCAVSKDIA NWQKKIGDIL RLVAGRIKNT FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRPF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 74 nTPM
- skeletal muscle: 61 nTPM
- skin: 56 nTPM
- choroid plexus: 51 nTPM
- blood vessel: 50 nTPM
- fallopian tube: 46 nTPM
Single-cell type
- early primary spermatocytes: 135 nCPM
- rod photoreceptor cells: 129 nCPM
- syncytiotrophoblasts: 127 nCPM
- oocytes: 120 nCPM
- innate lymphoid cells: 119 nCPM
- undifferentiated spermatogonia: 116 nCPM
Immune cell
- NK-cell: 131 nTPM
- naive CD4 T-cell: 96 nTPM
- MAIT T-cell: 93 nTPM
- total PBMC: 92 nTPM
- basophil: 91 nTPM
- memory CD4 T-cell: 83 nTPM
Brain region
- white matter: 74 nTPM
- cerebellum: 73 nTPM
- medulla oblongata: 59 nTPM
- pons: 57 nTPM
- basal ganglia: 57 nTPM
- midbrain: 55 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PRPF6.
Disease | AllUniProt
Conditions PRPF6 is implicated in, by any mechanism.
- Retinitis pigmentosa 60 (RP60) MIM:613983
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 743 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.44
- gnomAD pLI
- 0
- gnomAD missense Z
- 4.85
- DepMap mean gene effect
- -1.35
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA splicing, via spliceosome
- positive regulation of transcription by RNA polymerase II
- RNA localization
- RNA splicing
- RNA splicing, via transesterification reactions
- spliceosomal complex assembly
- spliceosomal tri-snRNP complex assembly
Molecular functions
- identical protein binding
- protein-macromolecule adaptor activity
- ribonucleoprotein complex binding
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- HAT (Half-A-TPR) repeat
- Tetratricopeptide-like helical domain superfamily
- Tetratricopeptide repeat
- Pre-mRNA-splicing factor Syf1-like
- Tetratricopeptide repeat
- Tetratricopeptide repeat
- PRP1 splicing factor, N-terminal
- PRP1 splicing factor, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRPF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRPF6 as an antibody target. Whether an autoantibody or antibody against PRPF6 could matter depends on whether native PRPF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRPF6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRPF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...